GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
25 juin 2024 08h00 HE
|
Genetic Technologies Ltd
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
21 juin 2024 08h00 HE
|
Genetic Technologies Ltd
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Genetic Technologies Expands Operational Capacity in North America
18 juin 2024 08h00 HE
|
Genetic Technologies Ltd
GeneType Expands Operational Capacity in North America
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
05 juin 2024 08h00 HE
|
Genetic Technologies Ltd
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
29 mai 2024 08h00 HE
|
Genetic Technologies Ltd
Genetic Technologies Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
GeneType and Humanise Health host “Know Your Risk” Event
23 mai 2024 08h00 HE
|
Genetic Technologies Ltd
"Know Your Risk" Event a remarkable success in Pasadena.
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
06 mai 2024 08h00 HE
|
Genetic Technologies Ltd
Genetic Technologies and 'Wellworks for You' sign B2B sales and marketing deal covering 750 employer groups and 2 million U.S. employees
Appendix 4C & Quarterly Business Update – March 2024
30 avr. 2024 08h00 HE
|
Genetic Technologies Ltd
Quarterly Business Update; Launching our most comprehensive test and expanding into new global markets
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
22 avr. 2024 15h00 HE
|
Genetic Technologies Ltd
Genetic Technologies Announces Closing of $2 Million Registered Direct Offering
Genetic Technologies Announces $2 Million Registered Direct Offering
18 avr. 2024 12h17 HE
|
Genetic Technologies Ltd
Genetic Technologies Announces $2 Million Registered Direct Offering